Soro Saferon Glenmark for treatment of iron deficiency (100ml)

Dosage form Syrup
Specifications Bottle
Ingredient Elemental iron
Indication Inflammation, iron deficiency anemia, menorrhagia

Ingredient

Thành phần cho 5ml

Composition information	Content
Elemental iron	50mg

Uses

Indications

Sato Saferon is indicated in the following cases:

Treatment of hidden iron deficiency and iron deficiency anemia.

Preventive reserve of iron, during and after pregnancy (during breastfeeding).

Make sure the amount of iron recommends eating daily (RDA) to prevent iron deficiency in children.

Pharmacology

The multi-core hydroxide hydroxid is covered with a non-binding polymaltose molecule, forming a molecular vol This complex is sustainable and does not release iron ions. In physiological conditions, iron in the nucleus of this multi -core molecule is connected in a structure similar to the structure of ferritin in terms of physiology. Thanks to this similarity, iron complex (III) is absorbed by the active absorption mechanism. By exchanging competitive coordination, any iron protein in digestive fluid and on the surface of the epithelial cell will receive iron (III). Iron (III) is absorbed and stored mainly in the liver, where it is attached to ferritin. Then, in the bone marrow, it will be integrated into Haemoglobin.

Hydroxid Polymaltose is not oxidized as iron salts (II). Oxidation of lipoproteins such as lipoprotein is very low density (VLDL) and low density lipoprotein (LDL). The syrup contains iron complex (III) Hydroxid Polymaltose does not cause tooth color change.

Dynamic pharmacokinetics

In studies using double isotopic techniques (55Fe and 59Fe), iron absorption in the form of Haemoglobin in erythrocytes is inversely proportional to the dose (the higher the dose, the lower the absorption). Statistical results show that there is a correlation between the level of iron deficiency and the amount of iron absorbed (the higher the shortage, the more absorption). The iron is most absorbed in the duodenum and the rosaries. The amount of iron not absorbed will be eliminated through feces. The elimination of iron through the peeling of the gastrointestinal epithelium and through the skin, as well as the sweat glands, bile, and urine about 1mg of iron/day.

For women, the amount of iron lost during the menstrual cycle also needs to be considered.

Before taking Soro Saferon Glenmark for treatment of iron deficiency (100ml)

How to use

Oral drugs.

Dosage

Dosage and treatment time depending on the level of iron deficiency.

Daily dose can be divided into small or disposable doses. Sato Saferon should be taken in or immediately after eating.

In the case of a clear iron deficiency, it is necessary to treat for about 3-5 months until the value of haemoglobin returns to normal. After that, it is necessary to continue treating for a few weeks with the indications for potential iron deficiency to supplement the amount of iron reserves.

Saferon 10ml dose

Disclosure iron deficiency

Hidden iron deficiency

Preventive treatment young children (under 1 year old) 5ml/day 20ml/day 5 - 10ml/day

Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose?

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using Saferon, you may experience unwanted effects (ADR).

Rarely occurs nausea, vomiting, diarrhea or constipation.

Instructions on how to handle ADR

Notify the doctor the unwanted effects occur when using the drug.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Saferon Sato contraindicated in the following cases:

Do not use for patients sensitive to any ingredients of the drug.

Anemia is not due to iron deficiency.

Patients with iron or iron assimilation disease.

Iron excess syndrome or iron overload.

Precautions when using

No report.

The ability to drive and operate machinery

does not affect the ability to drive and operate machinery.

Pregnancy

should only take the drug after the first 13 weeks of pregnancy.

Classification of pregnancy a.

Studies on animal fertility show that the drug does not cause harm on the fetus. Controlled studies on pregnant women after the first 3 months of pregnancy also show that the drug does not cause harm on the mother and the fetus. There is no evidence of the risk in women who use the drug in the first 3 months of pregnancy and certainly the drug does not cause harm on the fetus.

Breastfeeding period

Breastfeeding containing iron in De Lien with lactoferrin.

still cannot know the amount of iron from the drug is excreted in tamarind milk. Breastfeeding women will not cause any harm to breastfeeding.

Pregnant and lactating women should only use the drug when prescribed by a doctor.

Drug interaction

has not observed any drug interactions. Because iron in Saferon is in a complex form, there is almost no interactions between iron ions and ingredients of food (such as phytin, oxalate, tannin, etc.) and other oral medications (tetracyclin, antacids).

Saferon Saferon does not cause tooth color.

Storage

Store at temperatures below 30 ° C. Avoid light. To be out of reach of children.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.